Chronic Pain Optimization and Management for Relief and Functionality With TEA in Cirrhosis
Part of paid clinical trials in Ann Arbor, Michigan.
- Sponsor
- University of Michigan
- Study ID
- NCT07820917
- Status
- Not Yet Recruiting
Notify me when recruiting opens
Save your spot on the interest list for this study. We'll keep your details with this study so our team can follow up when recruiting opens.
Add your contact details and location so we can keep your interest tied to this study.
Conditions
- Cirrhosis
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - N/A
- Healthy Volunteers
- Not accepted
Interventions
- Transcutaneous Electrical Acustimulation (TEA) — DEVICEParticipant will apply TEA at home twice a day (approximately 45 minutes am/pm) for 8 weeks. The top electrode will be placed at an acupuncture point and the electrode patch will be placed vertically. Additionally, participants will agree to allow medical records to be collected, complete various surveys and have follow-up after treatment.
- Sham Transcutaneous Electrical Acustimulation (TEA) — DEVICEParticipant will apply sham TEA at home twice a day (approximately 45 minutes am/pm) for 8 weeks. Sham TEA will be performed via one point on the leg and not on any meridian or acupoints that were used in previous gastrointestinal studies and did not yield any significant effects. Additionally, participants will agree to allow medical records to be collected, complete various surveys and have follow-up after treatment
Study Details
This study is being done to better understand how the study team can treat pain for people with cirrhosis and depression. Enrolled participants on this feasibility study will be randomized to Transcutaneous Electrical Acustimulation (TEA) or sham TEA.
Key Dates
- First listed
- Sep 15, 2026
- Start date
- Sep 30, 2026
- Status verified
- Sep 2026
- Primary completion
- Sep 30, 2029
- Completion
- Sep 30, 2029
Study Design
- Enrollment
- 100 participants (estimated)
- Allocation
- RANDOMIZED
- Intervention model
- PARALLEL
- Primary purpose
- TREATMENT
Arms
- Experimental: Transcutaneous Electrical Acustimulation (TEA)Participants will have a two-week run-in period and then 8 weeks of treatment.
- Sham Comparator: TEA ShamParticipants will have a two-week run-in period and then 8 weeks of sham treatment.
Primary Outcome Measure
Retention [ Time Frame: Approximately day -14, day 1, and day 56 ]
Central Contacts
- Andrea MacMichael734-232-4182
Locations (2)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| University of Michigan | Ann Arbor | Michigan | 48109 | Elliot Tapper, MD (PRINCIPAL_INVESTIGATOR) |
| University of Pennsylvania | Philadelphia | Pennsylvania | 19104 | Marina Serper, MD, MS (PRINCIPAL_INVESTIGATOR) |
Find similar trials in Ann Arbor, MI
Related Studies
- Preventing Liver Cancer Mortality Through Imaging With Ultrasound vs. MRIRecruiting · VA Office of Research and Development · Birmingham, Alabama
- An Observational Study of Patients With Chronic Liver DiseaseEnrolling By Invitation · Target PharmaSolutions, Inc. · Los Angeles, California
- Liver Cirrhosis Network Rosuvastatin Efficacy and Safety for Cirrhosis in the United StatesPHASE2 · Recruiting · National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) · La Jolla, California
- Project OASIS: Optimizing Approaches to Select Implementation StrategiesEnrolling By Invitation · VA Office of Research and Development · Pittsburgh, Pennsylvania